Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Erik Iverson"'
Autor:
Erik Iverson
Most species will not be able to migrate fast enough to cope with climate change, nor evolve quickly enough with current levels of genetic variation. Exacerbating the problem are anthropogenic influences on adaptive potential, including the preventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73857a762121359d114eadcab66fa53
https://ecoevorxiv.org/gvpm9
https://ecoevorxiv.org/gvpm9
Autor:
Srivatsan Raman, Adam D. Silverman, Khalid K. Alam, Erik Iverson, Michael C. Jewett, Xiangyang Liu, Julius B. Lucks
Publikováno v:
ACS Synth Biol
Rapid molecular biosensing is an emerging application area for synthetic biology. Here, we engineer a portable biosensor for cyanuric acid (CYA), an analyte of interest for human and environmental health, using a LysR-type transcription regulator (LT
Autor:
Nancy F. Crum-Cianflone, Eugene V. Millar, Grace E. Macalino, Patrick J. Blair, Jason D. Maguire, Anuradha Ganesan, Lynn E. Eberly, Timothy Burgess, Carolyn Brandt, Erik Iverson, Dennis J. Faix, Tahaniyat Lalani, Christopher A. Duplessis, Timothy J. Whitman, Gabriel Defang
Publikováno v:
Vaccine. 29:3183-3191
Background Human immunodeficiency virus (HIV)-infected persons are at risk for severe influenza infections. Although vaccination against the H1N1 pandemic influenza strain is recommended, currently there are no data on the durability of post-vaccinat
Autor:
Nancy F. Crum-Cianflone, Timothy J. Whitman, Dennis J. Faix, Patrick J. Blair, Grace E. Macalino, Chris Duplessis, Gabriel Defang, Anuradha Ganesan, Carolyn Brandt, Jason D. Maguire, Lynn E. Eberly, Timothy Burgess, Erik Iverson, Tahaniyat Lalani, Yun Bai
Publikováno v:
Clinical Infectious Diseases. 52:138-146
Initial studies showed that a single dose of the novel inactivated 2009 influenza H1N1 vaccine was immunogenic in ∼95% of healthy adults [ 1, 2], resulting in its global production and distribution. Additional studies have shown that a 2-dose serie
Autor:
Erik Iverson, Regina Rabinovich
Publikováno v:
American Journal of Law & Medicine. 34:97-106
INTRODUCTION Thomas Jefferson - scientist, philosopher, and United States president firmly believed in the power of innovation. A bit of a tinkerer himself, he devoured new applications while serving as America's first patent examiner and often engag
Autor:
Jay N. Cohn, Pamela S. Douglas, Milton Packer, Karen P. Alexander, Camille G. Frazier, Susan Anderson, Sidney Goldstein, Erik Iverson, L. Kristin Newby
Publikováno v:
Journal of the American College of Cardiology. 49:1450-1458
Objectives This study sought to explore the gender-related differences in etiology and outcomes in chronic heart failure (HF) patients from 5 randomized trials. Background Each year, 550,000 new cases of HF are identified; however, there remain limit
Autor:
Gary Collins, Anuradha Ganesan, D. Faix, Lynn E. Eberly, Timothy Burgess, P. J. Blair, Tahaniyat Lalani, Brian K. Agan, Erik Iverson, Nancy F. Crum-Cianflone, Carolyn Brandt, Gabriel Defang, James H. Maguire, Timothy J. Whitman, Christopher A. Duplessis
Publikováno v:
Clinical and experimental immunology. 168(1)
Summary Immunoglobulin (Ig)G levels are important for antibody vaccine responses and IgG subclass deficiencies have been associated with severe 2009 influenza A (H1N1) infections. Studies have demonstrated variations in immune responses to the H1N1 v
Autor:
Glenn Wortmann, Jason F. Okulicz, Lynn E. Eberly, Amy C. Weintrob, J. Hartzell, Susan Fraser, Alan R. Lifson, C. Decker, Alicen B Spaulding, S. Merritt, Nancy F. Crum-Cianflone, Mark G. Kortepeter, Mary Bavaro, Sheila A. Peel, Brian K. Agan, G. Hsue, Tahaniyat Lalani, S. Banks, Grace E. Macalino, Michael A. Polis, Timothy J. Whitman, John H. Powers, Paige E. Waterman, Anuradha Ganesan, AM Johnson, Erik Iverson, M. Linfesty, Robert J. O'Connell, Tyler E. Warkentien, Michael Zapor, Edmund C. Tramont, Michael L. Landrum, Helen M. Chun, R. Rossner, C. Eggleston
Publikováno v:
Sexually transmitted infections. 88(4)
Objectives To investigate the epidemiology and risk factors of gonorrhoea (GC) or chlamydia (CT) coinfection in an HIV-positive US military cohort, focusing on the time after participants9 knowledge of HIV diagnosis. Methods The authors analysed data
Publikováno v:
Vaccine. 29(50)
Autor:
Angel Lanas, Robert S. Sandler, Robert H. Riddell, Erik Iverson, Dion Morton, John A. Baron, David L. DeMets, Robert S. Bresalier
Publikováno v:
Lancet (London, England). 372(9651)
Summary Background Selective inhibition of cyclo-oxygenase-2 has been associated with an increased risk of cardiovascular events in several clinical trials. The Adenomatous Polyp Prevention on Vioxx (APPROVe) study assessed the effect of 3-year treat